The Executive Director, National Primary Health Care Development Agency, Faisal Shuaib, on Thursday, March 18, revealed that the COVID-19 Oxford-Astrazeneca vaccine has been delivered to 35 out of the 36 states of the federation as well as the Federal Capital Territory.
According to Shuaib who addressed members of the National Economic Council, Kogi is the only state left out of the COVID-19 vaccine distribution.
The Senior Special Assistant to the Vice President on Media and Publicity, Laolu Akande, in a statement said the NPHCDA gave the update; while briefing a virtual meeting of NEC presided over by Vice-President Yemi Osinbajo.
The council chaired by sitting Vice Presidents has all state governors; governors of the Central Bank of Nigeria; and some relevant ministers as members.
Akande’s statement was titled “FG agency to NEC: COVID-19 vaccine delivered to 35 states, FCT.”
He quoted Shuaib as saying that Kogi has not received the vaccine; due to the issue of the cold-chain stores and the disposition of the state government.
The statement quoted the NPHCDA boss as saying “all states, except Kogi, have received their COVID-19 vaccines.
“Kogi State is yet to receive due to the non-repair of its Cold-Chain Store coupled with the state’s concerns around the contradictory information about the vaccines.
“The vaccination application has been launched in most states’ Treatment Centres; even against distractions as well as criticism of the FG’s efforts to ensure availability of vaccines in the nation.
“The roll-out of the vaccines across healthcare front-line workers; and also other health support staff was scheduled to commence by March 15, 2021, in some states; with the intention of wider coverage after the training of the states’ health workers across board.”
To ensure accountability in the distribution of the vaccine, Shuaib was also quoted as informing the council; that “the Independent Corrupt Practices and other Related Offences Commission had been co-opted to support the PTF on vaccine accountability to ensure the safekeeping of the vaccine.“